Amylyx Pharmaceuticals
AMLX
#5440
Rank
NZ$2.42 B
Marketcap
NZ$21.81
Share price
-0.93%
Change (1 day)
141.21%
Change (1 year)

Revenue for Amylyx Pharmaceuticals (AMLX)

Revenue in 2025 (TTM): N/A

a decrease over the revenue in the year 2024 that were of NZ$0.15 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Amylyx Pharmaceuticals from 2021 to 2025

Annual revenue

Year Revenue Change
2025 N/A-100%
2024 NZ$0.15 B-74.27%
2023 NZ$0.60 B1619.71%
2022 NZ$35.01 M
2021 N/A